Literature DB >> 1656403

GRF analogs and fragments: correlation between receptor binding, activity and structure.

R M Campbell1, Y Lee, J Rivier, E P Heimer, A M Felix, T F Mowles.   

Abstract

GH-releasing activity in vitro was directly correlated with GRF receptor binding affinity for all hGRF analogs examined. hGRF(1-29)-NH2 analogs with Ala15-substitution (for Gly15) displayed 4-5 times higher affinity for the GRF receptor relative to hGRF(1-44)-NH2. Replacement of Gly15 with Sar15 resulted in a dramatic loss of activity and receptor binding. The present data supports the proposal that Ala15-substitution increases receptor affinity, and hence potency, due to increased amphiphilic alpha-helical interactions. Fragments of hGRF, representative of DPP-IV and trypsin-like cleavage, are inactive as a consequence of greatly diminished GRF receptor binding. These results provide a comprehensive analysis of the structural features required for both GRF receptor binding and activation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1656403     DOI: 10.1016/0196-9781(91)90103-v

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  3 in total

1.  Human renal cell carcinoma expresses distinct binding sites for growth hormone-releasing hormone.

Authors:  G Halmos; A V Schally; J L Varga; A Plonowski; Z Rekasi; T Czompoly
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-12       Impact factor: 11.205

2.  Synthesis and biological evaluation of superactive agonists of growth hormone-releasing hormone.

Authors:  J Izdebski; J Pinski; J E Horvath; G Halmos; K Groot; A V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-23       Impact factor: 11.205

3.  Synthesis of new potent agonistic analogs of growth hormone-releasing hormone (GHRH) and evaluation of their endocrine and cardiac activities.

Authors:  Renzhi Cai; Andrew V Schally; Tengjiao Cui; Luca Szalontay; Gabor Halmos; Wei Sha; Magdolna Kovacs; Miklos Jaszberenyi; Jinlin He; Ferenc G Rick; Petra Popovics; Rosemeire Kanashiro-Takeuchi; Joshua M Hare; Norman L Block; Marta Zarandi
Journal:  Peptides       Date:  2013-12-25       Impact factor: 3.750

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.